GLP‐1RA vs placebo
Pancreatitis · CVD (ASCVD, HF, or both)
GLP‐1RA showed no clear difference in pancreatitis compared with placebo (low certainty).
1 finding from 1 review
- Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2… 2021 · Cochrane Headline outcomes onlyOR 0.96 [0.68, 1.35]5 studies · 40035 participantsLow